KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,702,422 | +30.8% | 58,577 | +9.6% | 0.50% | +34.3% |
| Q1 2023 | $9,709,021 | -7.6% | 53,452 | 0.0% | 0.37% | -6.8% |
| Q4 2022 | $10,503,318 | +97.7% | 53,452 | +126.3% | 0.40% | +82.9% |
| Q3 2022 | $5,312,000 | -46.9% | 23,616 | -70.1% | 0.22% | -44.8% |
| Q2 2022 | $10,002,000 | -21.5% | 79,057 | -21.3% | 0.39% | -12.1% |
| Q1 2022 | $12,737,000 | -3.2% | 100,458 | 0.0% | 0.45% | +5.7% |
| Q4 2021 | $13,160,000 | +7.1% | 100,458 | 0.0% | 0.42% | +6.8% |
| Q3 2021 | $12,289,000 | +7.3% | 100,458 | 0.0% | 0.40% | +6.5% |
| Q2 2021 | $11,451,000 | +11.7% | 100,458 | +17.9% | 0.37% | +5.4% |
| Q1 2021 | $10,248,000 | +18.4% | 85,236 | 0.0% | 0.35% | +16.1% |
| Q4 2020 | $8,659,000 | +167.7% | 85,236 | +103.8% | 0.30% | +151.2% |
| Q3 2020 | $3,234,000 | -2.9% | 41,827 | +40.0% | 0.12% | -4.7% |
| Q2 2020 | $3,330,000 | – | 29,873 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |